Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2022)
Medicure (MCUJF) posted quarterly Non-Current Deffered Revenue of $131869.8 for Q4 2022, up 155.73% year-over-year from $51566.8 in Q4 2021, and up 943.97% quarter-over-quarter from $12631.6 in Q1 2022.
Medicure (MCUJF) Non-Current Deffered Revenue (2009 - 2022) Analysis & Trends
Medicure's Non-Current Deffered Revenue history runs 13 years deep, the most recent figure standing at $131869.8 for Q4 2022.
- In Q4 2022, Non-Current Deffered Revenue rose 155.73% year-over-year to $131869.8; the TTM figure through Dec 2022 stood at $131869.8 (up 155.73% YoY), while the FY2022 annual figure was $137680.7, up 165.45% from the prior year.
- Non-Current Deffered Revenue for Q4 2022 stood at $131869.8, up from $12631.6 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $2.4 million in Q1 2018, with the low at $12631.6 in Q1 2022.
- The 5-year median for Non-Current Deffered Revenue is $737525.1 (2020), against an average of $894692.6.
- Peak annual rise in Non-Current Deffered Revenue reached 155.73% in 2022, while the deepest fall reached 94.27% in 2022.
- Medicure's Non-Current Deffered Revenue stood at $1.5 million in 2018, then slumped by 42.22% to $890818.1 in 2019, then tumbled by 71.15% to $256963.3 in 2020, then tumbled by 79.93% to $51566.8 in 2021, then jumped by 155.73% to $131869.8 in 2022.
- Business Quant data shows MCUJF's Non-Current Deffered Revenue at $131869.8 in Q4 2022, $12631.6 in Q1 2022, and $51566.8 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 131,869.83 |
| Mar 31, 2022 | 12,631.61 |
| Dec 31, 2021 | 51,566.85 |
| Sep 30, 2021 | 112,806.12 |
| Jun 30, 2021 | 167,586.59 |
| Mar 31, 2021 | 220,437.65 |
| Dec 31, 2020 | 256,963.31 |
| Sep 30, 2020 | 544,057.16 |
| Jun 30, 2020 | 597,878.07 |
| Mar 31, 2020 | 877,172.03 |
| Dec 31, 2019 | 890,818.07 |
| Sep 30, 2019 | 1.26 Mn |
| Jun 30, 2019 | 1.29 Mn |
| Mar 31, 2019 | 1.42 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Sep 30, 2018 | 2.12 Mn |
| Jun 30, 2018 | 2.25 Mn |
| Mar 31, 2018 | 2.36 Mn |
| Dec 31, 2017 | 2.29 Mn |
| Sep 30, 2017 | 2.49 Mn |